Education
About Us
Working with TipRanks
Follow Us
CellSource Co., Ltd. (JP:4880)
:4880
4880 Stock Chart & Stats
¥500.00
¥37.00(4.48%)
At close: 4:00 PM EST
¥500.00
¥37.00(4.48%)
Day’s Range― - ―
52-Week Range¥485.00 - ¥1,188.00
Previous CloseN/A
Volume210.70K
Average Volume (3M)77.65K
Market Cap
¥10.13B
Enterprise Value¥9.32B
Total Cash (Recent Filing)¥4.41B
Total Debt (Recent Filing)¥46.31M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Dec 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Oct 30, 2025Dividend Yield1.01%
Share Statistics
EPS (TTM)3.79
Shares Outstanding19,819,962
10 Day Avg. Volume73,510
30 Day Avg. Volume77,646
Financial Highlights & Ratios
PEG Ratio-1.31
Price to Book (P/B)3.89
Price to Sales (P/S)5.40
P/FCF Ratio451.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CellSource Co., Ltd. News
4880 FAQ
What was CellSource Co., Ltd.’s price range in the past 12 months?
CellSource Co., Ltd. lowest stock price was ¥485.00 and its highest was ¥1188.00 in the past 12 months.
What is CellSource Co., Ltd.’s market cap?
CellSource Co., Ltd.’s market cap is ¥10.13B.
When is CellSource Co., Ltd.’s upcoming earnings report date?
CellSource Co., Ltd.’s upcoming earnings report date is Dec 11, 2025 which is in 30 days.
How were CellSource Co., Ltd.’s earnings last quarter?
CellSource Co., Ltd. released its earnings results on Sep 11, 2025. The company reported ¥3.79 earnings per share for the quarter, beating the consensus estimate of N/A by ¥3.79.
Is CellSource Co., Ltd. overvalued?
According to Wall Street analysts CellSource Co., Ltd.’s price is currently Overvalued.
Does CellSource Co., Ltd. pay dividends?
CellSource Co., Ltd. pays a Annually dividend of ¥5 which represents an annual dividend yield of 1.01%. See more information on CellSource Co., Ltd. dividends here
What is CellSource Co., Ltd.’s EPS estimate?
CellSource Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CellSource Co., Ltd. have?
CellSource Co., Ltd. has 19,819,962 shares outstanding.
What happened to CellSource Co., Ltd.’s price movement after its last earnings report?
CellSource Co., Ltd. reported an EPS of ¥3.79 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.124%.
Which hedge fund is a major shareholder of CellSource Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4880
Company Description
CellSource Co., Ltd.
CellSource Co., Ltd. (4880) is a biotechnology company focused on the development and commercialization of innovative cellular therapies. The company operates primarily in the healthcare sector, specializing in stem cell research and regenerative medicine. CellSource's core products include advanced cellular treatments for various diseases and conditions, leveraging proprietary technology to enhance the efficacy and safety of therapies. The firm aims to transform patient care through its cutting-edge solutions that address unmet medical needs.
Technical Analysis
StemRIM Inc.
―
STELLA PHARMA CORPORATION
―
ReproCELL Inc.
―
StemCell Institute
―
CellSeed Inc.
―